Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth

Inflammation is strongly implicated in the pathogenesis of abdominal aortic aneurysms (AAA). This review examined the potential role of biologic disease-modifying anti-rheumatic drugs (bDMARDs) as repurposed drugs for treating AAA. Published evidence from clinical and preclinical studies was examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanigaimani, Shivshankar, Ibrahim, Muhammad, Golledge, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598733/
https://www.ncbi.nlm.nih.gov/pubmed/36289670
http://dx.doi.org/10.3390/biomedicines10102409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598733/
https://www.ncbi.nlm.nih.gov/pubmed/36289670
http://dx.doi.org/10.3390/biomedicines10102409

Ejemplares similares